# DKC1

## Overview
The DKC1 gene encodes dyskerin pseudouridine synthase 1, a multifunctional protein that plays a pivotal role in cellular processes such as ribosomal RNA processing and telomere maintenance. Dyskerin is a key component of the H/ACA ribonucleoprotein complex, where it facilitates the pseudouridylation of ribosomal RNA, a modification critical for ribosome biogenesis and function. Additionally, dyskerin is integral to the telomerase complex, contributing to the stabilization of the telomerase RNA component, which is essential for telomere elongation and cellular longevity (CarrascosoRubio2021Generation; Ge2010Dyskerin). The protein's interactions with other proteins and nucleic acids underscore its importance in maintaining cellular homeostasis and genomic integrity. Mutations in the DKC1 gene are associated with dyskeratosis congenita and other telomere-related disorders, highlighting its clinical significance in human health and disease (Niewisch2019An; Dokal2000Dyskeratosis).

## Structure
Dyskerin, encoded by the DKC1 gene, is a protein with a complex molecular structure essential for its function in ribosomal RNA processing and telomerase activity. The protein consists of 514 amino acid residues and has a molecular weight of approximately 58 kDa (Garus2021Dyskerin:). Dyskerin features several conserved domains, including the pseudouridine synthase and archaeosine transglycosylase (PUA) domain, the TruB_N pseudouridine synthase catalytic domain, and the Dyskerin-like domain (DKLD), which are crucial for its pseudouridylation activity and RNA binding (Garus2021Dyskerin:; Angrisani2014Human).

The protein's structure includes an L-shaped configuration with a β-sheet bisected by a catalytic cleft, surrounded by loop and helix motifs. A critical aspartic acid residue within this cleft is essential for enzymatic activity (Garus2021Dyskerin:). Dyskerin also contains nuclear and nucleolar localization signals rich in lysines, facilitating its subcellular localization (Garus2021Dyskerin:).

Dyskerin forms part of the H/ACA ribonucleoprotein complex, interacting with proteins such as NOP10, NHP2, and GAR1, and with H/ACA RNAs. This complex is crucial for the pseudouridylation process and telomerase function (Garus2021Dyskerin:; Ghanim20242.7). The protein undergoes post-translational modifications, including phosphorylation and sumoylation, which may regulate its activity (Angrisani2014Human). Dyskerin also has alternative isoforms that may play roles in ribosomal transport and translation (Angrisani2014Human).

## Function
The DKC1 gene encodes the protein dyskerin, which plays a crucial role in several cellular processes. Dyskerin is a component of small nucleolar ribonucleoprotein complexes (snoRNPs) and is involved in the pseudouridylation of ribosomal RNA (rRNA), a modification essential for proper rRNA processing and maturation (Meier2005The; Ge2010Dyskerin). This process is vital for ribosome biogenesis, as it ensures the structural stability and function of rRNA within ribosomes, which are critical for protein synthesis (Meier2005The).

Dyskerin is also a part of the telomerase complex, where it stabilizes the telomerase RNA component (TERC), contributing to telomere maintenance. This function is particularly important in somatic stem cells, where telomerase activity is necessary to counteract telomere shortening during cell division (CarrascosoRubio2021Generation). In erythroid cells, DKC1 is upregulated during differentiation, leading to increased telomerase activity and telomere lengthening, which supports cellular proliferation (Richards2019DKC1).

In the nucleolus, dyskerin's activity is crucial for maintaining the structure and function of nucleoli, impacting cell cycle regulation and ribosome biogenesis (Ge2010Dyskerin). Its absence can lead to impaired ribosome biogenesis and cell cycle arrest (Ge2010Dyskerin).

## Clinical Significance
Mutations in the DKC1 gene are primarily associated with dyskeratosis congenita (DC), a rare genetic disorder characterized by bone marrow failure, skin abnormalities, and an increased risk of cancer. DC is often inherited in an X-linked manner, with DKC1 mutations leading to defects in telomere maintenance, resulting in critically short telomeres and cellular dysfunction (Niewisch2019An; Dokal2000Dyskeratosis). The clinical manifestations of DC include dystrophic nails, oral leukoplakia, and abnormal skin pigmentation, and can progress to pulmonary fibrosis and liver cirrhosis (Ratnasamy2018Dyskeratosis).

DKC1 mutations are also linked to Hoyeraal-Hreidarsson syndrome, a severe variant of DC characterized by microcephaly, cerebellar hypoplasia, growth retardation, and aplastic anemia (Knight1999Unexplained). These mutations can lead to a wide range of clinical phenotypes, with some patients exhibiting severe symptoms such as early-onset bone marrow failure and immunodeficiency (Vulliamy2006Mutations).

Alterations in DKC1 expression or function can affect telomerase activity, leading to reduced telomerase RNA levels and compromised telomere maintenance. This can result in telomere-related disorders, including idiopathic pulmonary fibrosis and increased cancer susceptibility (Alder2013Telomere; Mitchell1999A). Female carriers of DKC1 mutations may exhibit subtle DC-associated features due to skewed X-chromosome inactivation (Xu2016Investigation).

## Interactions
DKC1 (dyskerin pseudouridine synthase 1) is a protein that participates in various interactions with other proteins and nucleic acids, playing a crucial role in cellular processes. DKC1 is a core component of the H/ACA small nucleolar ribonucleoprotein (snoRNP) complex, where it interacts with proteins such as NHP2 and GAR1. The interaction with NHP2 is mediated by SUMO interaction motifs (SIMs) in NHP2, and SUMOylation of DKC1 promotes its stability and interaction with NHP2. Mutation of these SIMs disrupts the interaction, highlighting the importance of SUMOylation in maintaining DKC1's functional associations (Wu2023SUMO).

DKC1 also interacts with the long noncoding RNA (lncRNA) PCAT1 in non-small cell lung cancer (NSCLC) cells. This interaction is significant for the regulation of cell proliferation, invasion, and apoptosis, as DKC1 and PCAT1 synergistically activate the VEGF/AKT/Bcl-2/caspase9 pathway (Liu2021LncRNA).

In embryonic stem cells, DKC1 functions as a coactivator for the transcription factors OCT4 and SOX2, essential for the transcription of pluripotency-related genes. It interacts with the XPC DNA repair complex, enhancing transcriptional activation of these genes, which is crucial for somatic cell reprogramming and stem cell maintenance (Fong2014The).


## References


[1. (Meier2005The) U. Thomas Meier. The many facets of h/aca ribonucleoproteins. Chromosoma, 114(1):1–14, March 2005. URL: http://dx.doi.org/10.1007/s00412-005-0333-9, doi:10.1007/s00412-005-0333-9. This article has 217 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00412-005-0333-9)

[2. (CarrascosoRubio2021Generation) Carlos Carrascoso-Rubio, Hidde A. Zittersteijn, Laura Pintado-Berninches, Beatriz Fernández-Varas, M. Luz Lozano, Cristina Manguan-Garcia, Leandro Sastre, Juan A. Bueren, Rosario Perona, and Guillermo Guenechea. Generation of dyskeratosis congenita-like hematopoietic stem cells through the stable inhibition of dkc1. Stem Cell Research &amp; Therapy, January 2021. URL: http://dx.doi.org/10.1186/s13287-021-02145-8, doi:10.1186/s13287-021-02145-8. This article has 1 citations.](https://doi.org/10.1186/s13287-021-02145-8)

[3. (Wu2023SUMO) Xiao Wu, Jian-Hui Li, Long Xu, Ya-Xiong Li, Xiao-Xu Zhu, Xi-Yu Wang, Xingmei Wu, Wei Zhao, Xuhao Ni, and Xiao-Yu Yin. Sumo specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via desumoylating dkc1. Cell Death &amp; Differentiation, 30(7):1742–1756, May 2023. URL: http://dx.doi.org/10.1038/s41418-023-01175-4, doi:10.1038/s41418-023-01175-4. This article has 4 citations.](https://doi.org/10.1038/s41418-023-01175-4)

[4. (Richards2019DKC1) Laura A. Richards, Ashu Kumari, Kathy Knezevic, Julie AI Thoms, Georg von Jonquieres, Christine E. Napier, Zara Ali, Rosemary O’Brien, Jonathon Marks-Bluth, Michelle F. Maritz, Hilda A Pickett, Jonathan Morris, John E. Pimanda, and Karen L. MacKenzie. Dkc1 is a transcriptional target of gata1 and drives upregulation of telomerase activity in normal human erythroblasts. Haematologica, 105(6):1517–1526, August 2019. URL: http://dx.doi.org/10.3324/haematol.2018.215699, doi:10.3324/haematol.2018.215699. This article has 17 citations.](https://doi.org/10.3324/haematol.2018.215699)

[5. (Fong2014The) Yick W Fong, Jaclyn J Ho, Carla Inouye, and Robert Tjian. The dyskerin ribonucleoprotein complex as an oct4/sox2 coactivator in embryonic stem cells. eLife, November 2014. URL: http://dx.doi.org/10.7554/elife.03573, doi:10.7554/elife.03573. This article has 40 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.03573)

[6. (Garus2021Dyskerin:) Alexandre Garus and Chantal Autexier. Dyskerin: an essential pseudouridine synthase with multifaceted roles in ribosome biogenesis, splicing, and telomere maintenance. RNA, 27(12):1441–1458, September 2021. URL: http://dx.doi.org/10.1261/rna.078953.121, doi:10.1261/rna.078953.121. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.078953.121)

[7. (Dokal2000Dyskeratosis) Inderjeet Dokal. Dyskeratosis congenita in all its forms. British Journal of Haematology, 110(4):768–779, September 2000. URL: http://dx.doi.org/10.1046/j.1365-2141.2000.02109.x, doi:10.1046/j.1365-2141.2000.02109.x. This article has 435 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1046/j.1365-2141.2000.02109.x)

[8. (Knight1999Unexplained) S. W. Knight, N. S. Heiss, T. J. Vulliamy, C. M. Aalfs, C. McMahon, P. Richmond, A. Jones, R. C. M. Hennekam, A. Poustka, P. J. Mason, and I. Dokal. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (hoyeraal‐hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, dkc1. British Journal of Haematology, 107(2):335–339, November 1999. URL: http://dx.doi.org/10.1046/j.1365-2141.1999.01690.x, doi:10.1046/j.1365-2141.1999.01690.x. This article has 189 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1046/j.1365-2141.1999.01690.x)

[9. (Liu2021LncRNA) Shi-Yuan Liu, Zhi-Yu Zhao, Zhe Qiao, Shao-Min Li, and Wei-Ning Zhang. Lncrna pcat1 interacts with dkc1 to regulate proliferation, invasion and apoptosis in nsclc cells via the vegf/akt/bcl2/caspase9 pathway. Cell Transplantation, January 2021. URL: http://dx.doi.org/10.1177/0963689720986071, doi:10.1177/0963689720986071. This article has 27 citations and is from a peer-reviewed journal.](https://doi.org/10.1177/0963689720986071)

[10. (Alder2013Telomere) Jonathan K. Alder, Erin M. Parry, Srinivasan Yegnasubramanian, Christa L. Wagner, Lawrence M. Lieblich, Robert Auerbach, Arleen D. Auerbach, Sarah J. Wheelan, and Mary Armanios. Telomere phenotypes in females with heterozygous mutations in the dyskeratosis congenita 1 (dkc1) gene. Human Mutation, 34(11):1481–1485, September 2013. URL: http://dx.doi.org/10.1002/humu.22397, doi:10.1002/humu.22397. This article has 102 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/humu.22397)

[11. (Niewisch2019An) Marena R. Niewisch and Sharon A. Savage. An update on the biology and management of dyskeratosis congenita and related telomere biology disorders. Expert Review of Hematology, 12(12):1037–1052, September 2019. URL: http://dx.doi.org/10.1080/17474086.2019.1662720, doi:10.1080/17474086.2019.1662720. This article has 128 citations and is from a peer-reviewed journal.](https://doi.org/10.1080/17474086.2019.1662720)

[12. (Vulliamy2006Mutations) Tom J. Vulliamy, Anna Marrone, Stuart W. Knight, Amanda Walne, Philip J. Mason, and Inderjeet Dokal. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood, 107(7):2680–2685, April 2006. URL: http://dx.doi.org/10.1182/blood-2005-07-2622, doi:10.1182/blood-2005-07-2622. This article has 395 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1182/blood-2005-07-2622)

[13. (Xu2016Investigation) Jialin Xu, Payal P. Khincha, Neelam Giri, Blanche P. Alter, Sharon A. Savage, and Judy M.Y. Wong. <scp>i</scp>nvestigation of chromosome x inactivation and clinical phenotypes in female carriers of dkc1 mutations. American Journal of Hematology, 91(12):1215–1220, November 2016. URL: http://dx.doi.org/10.1002/ajh.24545, doi:10.1002/ajh.24545. This article has 23 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1002/ajh.24545)

[14. (Mitchell1999A) James R. Mitchell, Emily Wood, and Kathleen Collins. A telomerase component is defective in the human disease dyskeratosis congenita. Nature, 402(6761):551–555, December 1999. URL: http://dx.doi.org/10.1038/990141, doi:10.1038/990141. This article has 893 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/990141)

[15. (Ghanim20242.7) George E. Ghanim, Zala Sekne, Sebastian Balch, Anne-Marie M. van Roon, and Thi Hoang Duong Nguyen. 2.7 å cryo-em structure of human telomerase h/aca ribonucleoprotein. Nature Communications, January 2024. URL: http://dx.doi.org/10.1038/s41467-024-45002-x, doi:10.1038/s41467-024-45002-x. This article has 1 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-024-45002-x)

[16. (Ge2010Dyskerin) Jingping Ge, David A. Rudnick, Jun He, Dan L. Crimmins, Jack H. Ladenson, Monica Bessler, and Philip J. Mason. Dyskerin ablation in mouse liver inhibits rrna processing and cell division. Molecular and Cellular Biology, 30(2):413–422, January 2010. URL: http://dx.doi.org/10.1128/mcb.01128-09, doi:10.1128/mcb.01128-09. This article has 36 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.01128-09)

[17. (Angrisani2014Human) Alberto Angrisani, Rosario Vicidomini, Mimmo Turano, and Maria Furia. Human dyskerin: beyond telomeres. Biological Chemistry, 395(6):593–610, January 2014. URL: http://dx.doi.org/10.1515/hsz-2013-0287, doi:10.1515/hsz-2013-0287. This article has 55 citations and is from a peer-reviewed journal.](https://doi.org/10.1515/hsz-2013-0287)

[18. (Ratnasamy2018Dyskeratosis) Vithiya Ratnasamy, Suganthan Navaneethakrishnan, Nirmala Dushyanthi Sirisena, Nana-Maria Grüning, Oliver Brandau, Kumanan Thirunavukarasu, Casey L. Dagnall, Lisa J. McReynolds, Sharon A. Savage, and Vajira H. W. Dissanayake. Dyskeratosis congenita with a novel genetic variant in the dkc1 gene: a case report. BMC Medical Genetics, May 2018. URL: http://dx.doi.org/10.1186/s12881-018-0584-y, doi:10.1186/s12881-018-0584-y. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12881-018-0584-y)